Computational translation of genomic responses from experimental model systems to humans

The high failure rate of therapeutics showing promise in mouse models to translate to patients is a pressing challenge in biomedical science. Though retrospective studies have examined the fidelity of mouse models to their respective human conditions, approaches for prospective translation of insigh...

Full description

Bibliographic Details
Main Authors: Haigis, Kevin M. (Author), Brubaker, Douglas (Contributor), Proctor, Elizabeth A (Contributor), Lauffenburger, Douglas A (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor)
Format: Article
Language:English
Published: Public Library of Science, 2019-02-21T21:16:34Z.
Subjects:
Online Access:Get fulltext
LEADER 02923 am a22002653u 4500
001 120530
042 |a dc 
100 1 0 |a Haigis, Kevin M.  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Biological Engineering  |e contributor 
100 1 0 |a Massachusetts Institute of Technology. Department of Biology  |e contributor 
100 1 0 |a Massachusetts Institute of Technology. Department of Chemical Engineering  |e contributor 
100 1 0 |a Brubaker, Douglas  |e contributor 
100 1 0 |a Proctor, Elizabeth A  |e contributor 
100 1 0 |a Lauffenburger, Douglas A  |e contributor 
700 1 0 |a Brubaker, Douglas  |e author 
700 1 0 |a Proctor, Elizabeth A  |e author 
700 1 0 |a Lauffenburger, Douglas A  |e author 
245 0 0 |a Computational translation of genomic responses from experimental model systems to humans 
260 |b Public Library of Science,   |c 2019-02-21T21:16:34Z. 
856 |z Get fulltext  |u http://hdl.handle.net/1721.1/120530 
520 |a The high failure rate of therapeutics showing promise in mouse models to translate to patients is a pressing challenge in biomedical science. Though retrospective studies have examined the fidelity of mouse models to their respective human conditions, approaches for prospective translation of insights from mouse models to patients remain relatively unexplored. Here, we develop a semi-supervised learning approach for inference of disease-associated human differentially expressed genes and pathways from mouse model experiments. We examined 36 transcriptomic case studies where comparable phenotypes were available for mouse and human inflammatory diseases and assessed multiple computational approaches for inferring human biology from mouse datasets. We found that semi-supervised training of a neural network identified significantly more true human biological associations than interpreting mouse experiments directly. Evaluating the experimental design of mouse experiments where our model was most successful revealed principles of experimental design that may improve translational performance. Our study shows that when prospectively evaluating biological associations in mouse studies, semi-supervised learning approaches, combining mouse and human data for biological inference, provide the most accurate assessment of human in vivo disease processes. Finally, we proffer a delineation of four categories of model system-to-human "Translation Problems" defined by the resolution and coverage of the datasets available for molecular insight translation and suggest that the task of translating insights from model systems to human disease contexts may be better accomplished by a combination of translation-minded experimental design and computational approaches. 
520 |a Boehringer Ingelheim Pharmaceuticals 
520 |a Institute for Collaborative Biotechnologies (Grant W911NF-09-0001) 
655 7 |a Article 
773 |t PLOS Computational Biology